| 8980927 |
Compounds having CRTH2 antagonist activity |
Richard Edward Armer, Mark Whittaker, Graham Michael Wynne, Julia Vile, Frank Schroer |
2015-03-17 |
| 8563536 |
Compounds having CRTH2 antagonist activity |
Richard Edward Armer, Mark Whittaker, Graham Michael Wynne, Julia Vile, Frank Schroer |
2013-10-22 |
| 8536158 |
Compounds having CRTH2 antagonist activity |
Richard Edward Armer, Mark Whittaker, Graham Michael Wynne, Julia Vile, Frank Schroer |
2013-09-17 |
| 8314257 |
Treatment of CRTH2-mediated diseases and conditions |
David Middlemiss, Mark Richard Ashton, Edward Andrew Boyd, Frederick Arthur Brookfield, Michael George Hunter +2 more |
2012-11-20 |
| 8198314 |
Treatment of CRTH2-mediated diseases and conditions |
David Middlemiss, Mark Richard Ashton, Edward Andrew Boyd, Frederick Arthur Brookfield, Michael George Hunter +2 more |
2012-06-12 |
| 8163936 |
Treatment of CRTH2-mediated diseases and conditions |
David Middlemiss, Mark Richard Ashton, Edward Andrew Boyd, Frederick Arthur Brookfield, Michael George Hunter +2 more |
2012-04-24 |
| 8163931 |
Treatment of CRTH2-mediated diseases and conditions |
David Middlemiss, Mark Richard Ashton, Edward Andrew Boyd, Frederick Arthur Brookfield, Michael George Hunter +2 more |
2012-04-24 |
| 7919512 |
Compounds having CRTH2 antagonist activity |
Richard Edward Armer, Mark Whittaker, Graham Michael Wynne, Julia Vile, Frank Schroer |
2011-04-05 |
| 7750027 |
Compounds having CRTH2 antagonist activity |
Richard Edward Armer, Mark Whittaker, Graham Michael Wynne, Julia Vile, Frank Schroer |
2010-07-06 |
| 7582672 |
Compounds for the treatment of CRTH2-mediated diseases and conditions |
David Middlemiss, Mark Richard Ashton, Edward Andrew Boyd, Frederick Arthur Brookfield, Michael George Hunter +2 more |
2009-09-01 |
| 5482944 |
Pyrimidones and imidazolinones for treatment of shock |
Victoria L. Cohan |
1996-01-09 |
